Clinical Investigation of the Safety and Efficacy of Low-temperature Plasma as an Adjuvant Treatment for Mild to Moderate Fungal Keratitis: A Pilot Study

References

• Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51:315–321.
   PubMedGoogle Scholar
• Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997;23:275–281.
   PubMedGoogle Scholar
• Sharma N, Chacko J, Velpandian T, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology. 2013;120(4):677–681. doi:10.1016/j.ophtha.2012.09.023.
   PubMed Web of Science ®Google Scholar
• Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128(6):672–678. doi:10.1001/archophthalmol.2010.102.
   PubMedGoogle Scholar
• Whitcher JP, Srinivasan M. Corneal ulceration in the developing world–a silent epidemic. Br J Ophthalmol. 1997;81(8):622–623. doi:10.1136/bjo.81.8.622.
   PubMed Web of Science ®Google Scholar
• Ansari Z, Miller D, Galor A. Current thoughts in fungal keratitis: diagnosis and Treatment. Curr Fungal Infect Rep. 2013;7(3):209–218. doi:10.1007/s12281-013-0150-1.
   PubMedGoogle Scholar
• Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis: a systematic review and meta-analysis. Cornea. 2016;35(1):62–71. doi:10.1097/ICO.0000000000000644.
   PubMed Web of Science ®Google Scholar
• Ozdemir HB, Kalkanci A, Bilgihan K, et al. Comparison of corneal collagen cross-linking (PACK-CXL) and voriconazole treatments in experimental fungal keratitis. Acta Ophthalmol. 2019;97(1):e91–e96. doi:10.1111/aos.13829.
   PubMed Web of Science ®Google Scholar
• Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012;31(2):176–180. doi:10.1097/ICO.0b013e318221cec7.
   PubMed Web of Science ®Google Scholar
• Makdoumi K, Backman A, Mortensen J, Crafoord S. Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol. 2010;248(2):207–212. doi:10.1007/s00417-009-1231-2.
   PubMed Web of Science ®Google Scholar
• Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci. 2010;51(8):3950–3953. doi:10.1167/iovs.09-4013.
   PubMed Web of Science ®Google Scholar
• Uddaraju M, Mascarenhas J, Das MR, et al. Corneal cross-linking as an adjuvant therapy in the management of recalcitrant deep stromal fungal keratitis: a randomized trial. Am J Ophthalmol. 2015;160(1):131–134 e135. doi:10.1016/j.ajo.2015.03.024.
   PubMed Web of Science ®Google Scholar
• Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006;113(4):526–530. doi:10.1016/j.ophtha.2005.10.063.
   PubMed Web of Science ®Google Scholar
• Gay-Mimbrera J, Garcia MC, Isla-Tejera B, Rodero-Serrano A, Garcia-Nieto AV, Ruano J. Clinical and biological principles of cold atmospheric plasma application in skin cancer. Adv Ther. 2016;33:894–909.
   PubMed Web of Science ®Google Scholar
• von Woedtke T, Reuter S, Masur K, Weltmann KD. Plasmas for medicine. Phys Rep. 2013;530:291–320.
   Google Scholar
• Souskova H, Scholtz V, Julak J, Kommova L, Savicka D, Pazlarova J. The survival of micromycetes and yeasts under the low-temperature plasma generated in electrical discharge. Folia Microbiol (Praha). 2011;56(1):77–79. doi:10.1007/s12223-011-0005-5.
   PubMed Web of Science ®Google Scholar
• Dd GV. Medical microplasmatron. 3rd International Workshop on Microplasmas (IWM-2006). 2006; Greifswald, Germany.
   Google Scholar
• Ksh PHJ, W JH, Ju HW, et al. Microplasma jet arrays as a therapeutic choice for fungal keratitis. Sci Rep. 2018;8(1):2422. doi:10.1038/s41598-018-20854-8.
   PubMedGoogle Scholar
• Konstantopoulos A, Kuo J, Anderson D, Hossain P. Assessment of the use of anterior segment optical coherence tomography in microbial keratitis. Am J Ophthalmol. 2008;146(4):534–542.e532. doi:10.1016/j.ajo.2008.05.030.
   PubMed Web of Science ®Google Scholar
• Kong MG, Kroesen G, Morfill G, et al. Plasma medicine: an introductory review. J New J Phys. 2009;11(11):115012. doi:10.1088/1367-2630/11/11/115012.
   Google Scholar
• Helmke A, Grunig P, Fritz UM, et al. Low-temperature plasma - a prospective microbicidal tool. J Recent Patents Anti-Infective Drug Discovery. 2012;7(3):223–230. doi:10.2174/157489112803521995.
   PubMedGoogle Scholar
• Augusto O, Bonini MG, Amanso AM, Linares E, Santos CC, De Menezes SL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med. 2002;32(9):841–859. doi:10.1016/S0891-5849(02)00786-4.
   PubMed Web of Science ®Google Scholar
• Ehlbeck J, Schnabel U, Von Woedtke T, et al. Low temperature atmospheric pressure plasma sources for microbial decontamination. J Phys D Appl Phys. 2010;44(1):13002–13019(13018). doi:10.1088/0022-3727/44/1/013002.
   Web of Science ®Google Scholar
• Laroussi M. Low temperature plasma-based sterilization: overview and state-of-the-art (p 391-400). Plasma Processes Polymers. 2005;2(5):391–400. doi:10.1002/ppap.200400078.
   Web of Science ®Google Scholar
• Montie TC, Kelly-Wintenberg K, Roth JR. An overview of research using the one atmosphere uniform glow discharge plasma (OAUGDP) for sterilization of surfaces and materials. J IEEE Transactions Plasma Sci. 2000;28(1):41–50. doi:10.1109/27.842860.
   Web of Science ®Google Scholar
• Perni S, Shama G, Hobman JL, et al. Probing bactericidal mechanisms induced by cold atmospheric plasmas with Escherichia coli mutants. Appl Phys Lett. 2007;90(7):073902. doi:10.1063/1.2458162.
   Web of Science ®Google Scholar
• Wei LC, Tsai T-C, Tsai H-Y, Wang C-Y, Shen Y-C. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application. Curr Eye Res. 2013;35(7):573–579. doi:10.3109/02713681003760135.
   Google Scholar
• Weltmann KD, Kindel E, von Woedtke T, M H, Stieber M, Brandenburg R. Atmospheric-pressure plasma sources: prospective tools for plasma medicine. Pure Appl Chem. 2010;82(6):1223–1237. doi:10.1351/PAC-CON-09-10-35.
   Web of Science ®Google Scholar
• Fridman G, Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Processes Polymers. 2008;5(6):503–533. doi:10.1002/ppap.200700154.
   Web of Science ®Google Scholar
• Chen Kang CX, Chi Q, Xuqin L, Yao T, Jia L. Clinical comparison between low-temperature plasma and conjunctival autograft in primary pterygium. Chin J Pract Ophthalmol. 2017;35:32–36.
   Google Scholar
• Xu LJ, Song XS, Jing Z, Sun SY, Lxjcmj X. Hypopyon in patients with fungal keratitis. J Chin Med J. 2012;125:470–475.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhai HL, Wang JY, et al. [Clinical features and treatments of retrocorneal fungal infection]. Zhonghua Yan Ke Za Zhi. 2017;53(10):758–765. doi:10.3760/cma.j.0412-4081.2017.10.008.
   PubMedGoogle Scholar